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Introduction
Adherence to medication regimens has been
monitored since the time of Hippocrates.1 It has become a
focus of increasing concern in the treatment of psychiatric
disorders in recent years.2 Adherence to a medication
regimen is generally defined as the extent to which patients
take medications as prescribed by their health care
providers.1 It includes data on dose taking (taking the
prescribed number of pills each day) and the timing of doses
(taking pills within a prescribed period). Non-adherence to
treatment is the degree to which a patient does not carry out
the clinical recommendations of a treating physician,3 Non-
adherence is a significant problem in all patient populations,
from children4 to elderly.5 Adherence rates are typically
higher among patients with acute conditions, as compared
to those with chronic conditions.6 This tends to worsen the
longer a patient continues on drug therapy.7
Medication adherence rates reported for populations
with psychiatric illness ranges from 24 to 90 percent for
patients treated with antipsychotic medication and 40 to 90
percent for patients treated with antidepressants.2 Another
set of patients will never start or will stop therapy
completely within the first year, and only a minority will
continue taking drugs as prescribed.7 An overview of the
extensive literature on medication adherence found no
differences in adherence rates between populations with
physical disorders and those with psychiatric disorders.8
Adherence is a poly-faceted problem but a triadic
model relating therapeutic relationship between the patient
and clinician, factors related to the medications and factors
related to the patients and their illness help explain the non
adherent behavior.9 Physicians contribute to the non-
adherence by failing to prescribe simple regimens, not
explaining the benefits and side-effects of medication, not
considering patients' lifestyle or medication cost involved
and inadequately eliciting and rectifying the myths and
beliefs held by patients.9,10 According to Cramer et al.,
typical reasons for not taking medications include
forgetfulness, other priorities, decision to omit doses, lack
of information, and emotional factors.11 Supervision by a
clinical trustee in cases of absence of insight on patient's
behalf is a significant factor for adherence as well.12
Non-adherence also has economic implications.
Poor adherence to medication regimens accounts for
substantial worsening of disease, death, and increased
health care costs in the United States.13 Of all medication-
related hospital admissions in the United States, 33 to 69
percent are due to poor medication adherence, with a
resultant cost of approximately $100 billion a year.14 In less
developed part of the world, cost of treatment and
medications deserves greater attention as patients pay
almost exclusively out-of-pocket in the absence of well
developed public health care and insurance cover. A study
from Pakistan reported that 16.32% (56/343) had stopped
taking medication primarily because of inability to pay.15
Thus information about factors that influence adherence and
methods for facilitating optimal use of medication are
especially important.2
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Abstract
Objective: To elucidate predictors of non-adherence among psychiatric patients presenting at a tertiary care
hospital of Pakistan, for follow-up with consultant psychiatrist. 
Methods: A convenient sample of psychiatric patients from Aga Khan University Hospital was enrolled between
April and May, 2005. An interviewer assisted, standardized questionnaire was used for data collection. Patients
with cognitive deficit or psychosis and those presenting for the first time were not included in the study. 
Results: Out of 128 patients, those with co-morbidity (32.81%) were less adherent than those without co-
morbidity (p-value:0.002). Adherence among depressed was 61.53%; psychotic was 58.82%; bipolar disorder
was 73.91%. Reasons for non-adherence included sedation (30%), medication cost (22%), forgot to take
medication (36%); and inability of the physicians to explain timing and dose (92%) or benefit of medication (76%).
Conclusions: Non-adherence is a common and important issue. Treatment cost and co-morbidity should be
reviewed in order to keep the medication regime affordable and comprehensible (JPMA 58:432;2008).
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Advancements in the treatment of psychiatric
disorders are limited by non-adherence, which steal power
from even the most beneficial medications. The World
Health Organization recognized the importance and
magnitude of non-adherence and published an evidence-
based guide to improve strategies of medication
adherence.16
Data on the predictors of non-adherence from
developing countries, especially Pakistan, is scarce.
Information in this regard will help design effective
interventions and therapeutic techniques for enhancing
adherence behaviour among psychiatric patients. Better
adherence will certainly translate in improved treatment
efficacy, better intervention outcome and reduction of cost
burden on health care.
The objective of this study was to elucidate
predictors of non-adherence among psychiatric patients
presenting at a tertiary care hospital of Pakistan.
Patients and Methods
This cross-sectional study was conducted at the out-
patients services of psychiatry unit of Aga Khan University
Hospital (AKUH). A convenient, non-probability sample of
one hundred and thirty five follow-up patients between
April 23 and May 11, 2005 were enrolled. All patients
above the age of 18 years that had been previously seen by
a consultant psychiatrist and were on prescription
medications without any restriction of sex, marital status,
educational level, socioeconomic status and place of
residence were included in the study. Patients with cognitive
deficit or acute psychosis and patients presenting for the
first time (index visit at AKUH) were not included. An
informed consent was taken from patients. An interviewer
assisted standardized questionnaire was designed for this
purpose which was administered by a group of fourth year
medical students rotating through the clinical psychiatry
clerkship. Standardized pattern of enquiry was devised in
order to minimize interviewer bias. 
Data was managed using SPSS for Windows Version
14. Frequency tables were obtained and chi-square analysis
was done for the variables of interest.
A 19 item questionnaire was devised after thorough
literature search, identifying key aspect of non-adherence.
Questionnaire was pre-tested on small sub sample in order
to identify any potential problems in data collection and to
extend the list of reasons, beyond those already identified in
literature, including any local/traditional factors. The final
questionnaire included the traditional factors 'garam/thandi'
and 'khushk/tar', in addition to list already in the initial
questionnaire.
Final questionnaire inquired about demographic
variables, psychiatric diagnosis and medical co-morbidity,
number of medications on daily basis and schedule, and
supervision on administration. The questionnaire also
inquired reasons for non-adherence based upon the
proposed triadic model, including factors pertaining to
physicians, patients and medications. 
We adopted a modified version of the World Health
Organization's definition as operational definition for non-
adherence for our study. We defined non-adherence as
'missing medications three consecutive times, two times in
a week, five times in a month or change in the dose of the
medications without advice of the prescribing physician. 
Results
We enrolled a total of 135 patients, seven out of them
were excluded as they did not complete the interview
process, thereby, leaving 128 in the final sample. 
Mean age of patients was 39.49 years.
Demographics of our study population are given in Table 1.
Those who were employed included twenty-one
professionals (16.40%), four skilled labourers (3.90%),
three land-lords (2.34%) and sixteen were self employed
(12.5%). Out of these, professional and land-lords showed
highest adherence (76.19% and 80% respectively). Among
un-employed forty-nine were housewives (38.28%), of
which twenty-seven (55.10%) were adherent and twenty-
two (44.90%) were non-adherent. 
One of the significant findings of our study was non-
adherence among those who had co-morbidity (Table 1).
Out of a total of one hundred and twenty-eight, forty-two
patients (32.81%) had some form of co-morbidity, with only
eighteen (42.85%) being adherent patients. Out of eighty-
six (67.19%) who did not have any co-morbidity, most
(70.93%) were adherent (p-value: 0.002). Almost half of our
study patients had depressive disorder (50.78%). Patients
with psychotic disorders (26.54%) had least prevalence of
adherence (Table 1). Eighty-six (67.19%) patients took their
medications on their own, adherent being 54 (62.79%) and
non-adherent being 34 (37.21%) while among forty-two
patients who were given medication by their relatives
(32.81%), twenty-four (57.14%) were adherent and
eighteen (42.86%) were non-adherent. Most of the patients
(89.84%) were in the practice of regular follow-up with
their prescribing physician. Out of these, seventy-three
(63.47%) were adherent and forty-two (36.53%) were not
adherent to their medication.
Most patients identified factors related to physicians
(Physician factors) as their reason for non-adherence.
Figure 1 shows a detail of reasons identified by patients for
their non-adherence.
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Table 1 - Demographics, Diagnosis, Co-morbidity, Medication administration and Follow-up with prescribing consultant.
Demographics Total Adherent Non-adherent P-Value
Mean age (years) 39.49 ± 13.78 39 ± 13.74 40.26 ± 13.83 
Mean income (Rupees) 29.32 ± 3.67 26.48 ± 3.10 34.57 ± 3.37
Mean illness duration (m) 56.05 ± 5.48 56.29 ± 6.05 55.67 ± 6.12
Mean number of tablets 4.50 ± 1.08 4.40 ± 1.03 4.67 ± 1.12
Mean duration since last visit (weeks) 7.72 ± 2.54 7.72 ± 2.40 9.51 ± 2.62
Sex % (n)
Male 49.21 (63) 55.55 (35) 44.55 (28)
Female 50.69 (65) 66.15 (43) 33.85 (22)
Marital status % (n)
Single 35.93 (46) 71.73 (33) 28.27 (13)
Married 64.07 (82) 57.33 (47) 42.67 (35)
Employment status % (n) 
Unemployed 54.68 (70) 60.00 (42) 40.00 (28)
Employed 28.90 (37) 59.50 (22) 40.50 (15)
Student 9.37 (12) 75.00 (9) 25.00 (3)
Others 7.02 (9) 66.67 (6) 33.33 (3)
Diagnosis % (n)
Depressive disorder 50.78 (65) 61.53 (40) 38.47 (25)
Psychotic disorder 26.56 (34) 58.82 (20) 41.18 (14)
Bipolar disorder 17.96 (23) 73.91 (17) 26.09 (6)
Co-morbidity % (n)
Yes 32.81 (42) 42.85 (18) 57.15 (24)
0.002*
No 67.19 (86) 70.93 (61) 29.07 (25)
Medication Administration %
(n)
Self 67.19 (86) 62.79 (54) 37.21 (34)
Relative 32.81 (42) 57.14 (24) 42.86 (18)
Follow-up with prescribing
physician % (n)
Yes 89.84 (115) 63.47 (73) 36.53 (42)
No 10.15 (13) 85.71 (11) 14.29 (2)
Figure 1. Reasons for non-adherence.
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Discussion
Non-adherence to medication regimens is a serious
problem. It has many serious effects on prognosis of the
illness and overall effectiveness of health systems. Non-
adherence may signal that patient and physician differ over
goals and priorities regarding the treatment and its
schedule..17 Non-adherent patients are more severely ill at the
point of readmission to hospital, have more frequent
readmissions, are more likely to be admitted compulsorily,
and have longer inpatient stays.18 Increasing the effectiveness
of adherence interventions may have a far greater impact on
the health of the population than any improvement in specific
medical treatments.19 Therefore, information regarding
factors influencing optimal use of medications is vital.2
Various reasons for non-adherence came into view in
this study including co-morbidity, type of illness, cost of
treatment, a list of personal factors and side effects of
medication being prescribed. Along with these reasons,
various social and cultural myths and beliefs regarding
psychiatric medication, use of alternative medicine and
clinician-patient therapeutic alliance or relationship were also
important factors contributing to non-adherence. Self
reporting of non-adherence, the method we adopted in our
study, has a sensitivity of 72.2 percent and specificity of 74.1
percent.20 However, it underestimate the actual prevalence,
proven by comparison with micro-electric monitoring, which
usually shows 15-20 percent higher prevalence of non-
adherence than self reporting.20 It is safe to argue that, in our
patients, actual prevalence of non-adherence is higher than 39
percent.2,15
Among different psychiatric illnesses, patients
suffering from psychotic disorders (41.18%) are the most
likely not to comply, followed by those suffering from
depressive disorders (38.47%) and those suffering from
bipolar disorder (26.09%). This is in concordance with
previous studies. Elixhauser et al.21 showed that 74 percent of
outpatients with schizophrenia stop taking neuroleptics or
antipsychotics within two years of leaving a hospital and 20
to 57 percent patients with bipolar affective disorder are non-
adherent.
The clinician-patient therapeutic relationship acts as a
vehicle of change and adherence to medications. This
relationship includes incorporation of the patient's
perspective into a relationship-centered medical paradigm,22
time given by physician in explaining the effect and side
effects of the medications, explanation given regarding the
lag in the efficacy and relief of distressing symptoms of the
illness. This also includes eliciting various myths and beliefs
held by patients and rectifying these ideas with objective
scientific information and explanations. Lastly, explanation
by the physician on the consequences of missing the
medication is also included in the physician-patient
therapeutic relation. Our study showed that the most common
reason for non-adherence was failure of clinician-patient
therapeutic relationship. Ninety-two percent of the non-
adherent patients reported that their physician did not explain
the timing and dose of their medication adequately or
completely. Physicians also failed to adequately explain the
benefit of prescription, possible side effects, time lag before
onset of treatment response and consequence of non-
adherence.
There was a strong correlation between presence of a
co-morbidity and non-adherence among the patients in our
study. Co-morbidity is likely to increase the number of
medications being taken by the patient. This increase makes
the medication regimen complex, costly and cumbersome for
the patients to follow or incorporate into routine. Also, co-
morbidity means more logistic problems in seeking medical
advice from more than one treating physician, keeping
appointments or getting the medication refills on time. 
We came across the following common self-reported
personal factors of the patients: 'I forgot to take medication'
(36%), 'I thought I am better now and do not need to take
medication' (32%), 'treatment was of little benefit' (30%) and
'I had to take too many pills' (24%). These personal factors
may have a causal relationship with inability of the physician
to communicate effectively the timing, dose of medication
(92%) and consequence of missing a dose (54%), explaining
total duration of therapy and consequence of non-adherence,
inability to communicate side effects related with the
medication being used, time lag before onset of treatment
response and strong correlation between non-adherence and
co-morbidity, respectively. It is worthwhile to note that high
emphasis on timing and dose is ineffective without patient
education. It is imperative for the physician to establish a
successful clinician-patient alliance/relationship, as it is the
vehicle of change and adherence. In non-adherent patients',
lack of treatment response can lead to their being switched
from one drug to another, with little success because they do
not take the drug as prescribed.2
Psychotropic medications commonly used for
treatment of psychiatric illnesses have a well demonstrated
and documented number of unpleasant side effects, ranging
from restlessness to sedation, tremor, dry mouth,
constipation, impotence, weight gain, missed menstrual
cycles and many others. Our study showed that the side effect
of psychotropic drugs is a common reason for non-adherence
with sedation (30%) being the leading cause.
Unlike previous studies from Pakistan,15,23 our study
did not show cost of treatment, consultation or travelling to
seek medical advice as the most common reason for non-
adherence. Possible explanation includes the highly effective
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patient welfare programme, at the hospital where study was
done, which takes care of non-affording patients. This could
also be due to the belief that a big proportion, not a majority,
of patient population presenting at the clinics belong to higher
socio-economic stratum of the society. 
Considering the realisation of importance of treatment
most of the patients stop medications because of illiteracy or
lack of insight. This behaviour is further precipitated by the
stigma to psychiatric illnesses, treatment from quacks and
traditional faith healers and hostility, non-cooperation or
inaccessibility of some doctors (3%).23 Our study failed to
acknowledge these factors as reasons for non-adherence, which
could be due to a positive impact of treating physicians in this
regard. However, some participants of our study reported
'garam/thandi' or 'Khushk/tar' as their reason for non-adherence.
These are common traditional myths that are prevalent in the
local society especially in relation to psychiatric medications
and stem from the traditional/alternative medicine practiced in
our society. 'Garam/thandi' literally means 'hot/cold' and it is
believed that some constituents of the medications have hot or
cold effect on the body, which results in a number of side effects
including hypertension, diarrhoea, sexual problems etc.
'khushk/tar' literally means 'dry/wet' and it is believed that some
constituents of medication makes the body, especially the mind,
dry and others wet that in turn makes a person vaguely similar
to cyclic manic-depressed. This myth extends to include a
number of illnesses, including the common cold, as dry or wet
effect of the medication. These myths are believed to be
prevalent across all socio-economic divides independent of the
level of education. 
The study was limited by the following facts: The
setting of study is confined to an affluent hospital of Pakistan
which may not necessarily represent the general population of
the country, sample size is small, use of self-reporting methods
which are inferior to more sophisticated micro-electric
monitoring, and recall bias associated with self-reporting.
Conclusion
Non-adherence is a common, prevalent and important
issue in the treatment of psychiatric illnesses. Efforts are
needed to improve the adherence among patients. We
recommend that psychiatrists should work towards better
clinician-patient relationship. More emphasis should be laid
on patient education which should include effective
advocacy, better explanation of dose, timing and duration of
use of medication, associated side effects and lag before the
onset of effect of treatment as well as elaborately discussing
consequences of non-adherence. We also recommend that
overall cost of treatment should be kept in view and low cost
alternatives or generic should be prescribed without
compromising the efficacy of treatment. Psychiatrists, as well
as other physicians, should be observant on co-morbids and
number of drugs in use in order to keep the medication
regimen simple. 
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